AzTrials
AzTrials

Cerebral Palsy InfantileHOMIMTES-CHilDNCT07091461

HOMe-IMprove Telerrehabilitation System

A study testing HOME Kit Tablet-based Telerehabilitation and Conventional Home Physiotherapy in people with Cerebral Palsy Infantile, run by University of Castilla-La Mancha.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This pilot study aims to assess the feasibility, adherence, and preliminary efficacy of a home-based telerehabilitation protocol using the HOME Kit Tablet system in children aged 6 to 18 years with cerebral palsy. The study follows a randomized controlled design with parallel groups and single-blind evaluation. Read more about this study

Who is it for?
Ages 6 to 18 years
Conditions the study is for
Cerebral Palsy Infantile
What is being tested?
HOME Kit Tablet-based Telerehabilitation and Conventional Home Physiotherapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
No sites listed yet
Study dates
1 Mar 2026to 1 Apr 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Confirmed diagnosis of infantile unilateral cerebral palsy
  • Age between 6 and 18 years
  • Stable home Wi-Fi access and space to perform exercises
  • Manual Ability Classification System (MACS) level ≤ 3
  • Informed consent from legal guardian and assent from the child (if <12 years)

Who cannot join

  • Severe neurological or psychiatric comorbidities
  • Recent orthopedic surgery (<12 months) or botulinum toxin treatment (<6 months)
  • Concurrent participation in other intervention studies

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Rocío Palomo-Carrión, PT PhD contact

34926051821

Rocio.Palomo@uclm.es

About this study

Official title: HOMe-IMprove Telerrehabilitation System for CHilDren With Cerebral Palsy

This pilot study aims to assess the feasibility, adherence, and preliminary efficacy of a home-based telerehabilitation protocol using the HOME Kit Tablet system in children aged 6 to 18 years with cerebral palsy. The study follows a randomized controlled design with parallel groups and single-blind evaluation. The intervention group will use a digitally supervised rehabilitation system, while the control group will follow a traditional home therapy protocol without technological tools.

Being tested
HOME Kit Tablet-based Telerehabilitation, Conventional Home Physiotherapy
Keywords
home, children, infantile cerebral palsy, family, upper extremity, balance
Medical subject headings
Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HOME Kit Tablet-based TelerehabilitationDevice

    Device-based behavioral intervention (motor, cognitive, and communication rehabilitation)

  • Conventional Home PhysiotherapyOther

    Participants in this arm will follow a conventional home rehabilitation protocol, focusing on upper limb function and postural control. The protocol includes traditional exercises prescribed and explained by a physiotherapist. Follow-up will be conducted through weekly phone calls to reinforce adherence and resolve concerns.

Study groups in NCT07091461
Study groupRoleWhat they receive
HOME Kit Tablet TelerehabilitationExperimentalParticipants in this arm will receive a structured telerehabilitation program using the HOME Kit Tablet system, which includes a touchscreen tablet with therapeutic software, inertial measurement unit (IMU) sensors, digital scales, a K-wand, and a stabilometric platform. Sessions are remotely supervised in real time by a trained physiotherapist who personalizes the activity protocol according to individual performance.
Receives: Device: HOME Kit Tablet-based Telerehabilitation
Conventional Home PhysiotherapyActive comparatorParticipants in this arm will follow a conventional home rehabilitation protocol, focusing on upper limb function and postural control. The protocol includes traditional exercises prescribed and explained by a physiotherapist. Follow-up will be conducted through weekly phone calls to reinforce adherence and resolve concerns.
Receives: Other: Conventional Home Physiotherapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in postural control assessed by stabilometric platform

    Postural control is evaluated using a stabilometric platform, which quantitatively measures center of pressure (CoP) displacement and sway area during quiet standing. The main outcome is the mean sway area in square centimeters (cm²), with lower values indicating better postural stability.

    Measured: baseline, immediately after the intervention, 1 month after intervention

  2. Change in balance performance assessed by the Pediatric Berg Balance Scale (PBS)

    The PBS is a 14-item observational tool designed to measure balance in children. Scores range from 0 to 56; higher scores indicate better balance function.

    Measured: baseline, immediately after the intervention, 1 month after intervention

  3. Change in unimanual hand function assessed by the Assisting Hand Assessment (AHA)

    The AHA measures how effectively children with unilateral cerebral palsy use their affected hand in bimanual tasks. Total scores range from 0 to 100; higher scores indicate better hand function.

    Measured: baseline, immediately after the intervention, 1 month after intervention

  4. Change in upper limb performance assessed by the Shriners Hospital for Children Upper Extremity Evaluation (SHUEE)

    The SHUEE evaluates spontaneous and dynamic use of the upper limb. Scores range from 0 to 100; higher scores indicate better function.

    Measured: baseline, immediately after the intervention, 1 month after intervention

  5. Change in manual ability assessed by the Children's Hand-use Experience Questionnaire (CHEQ)

    The CHEQ is a parent-reported measure that assesses the child's experience using their affected hand in daily tasks. Item scores and mean summary scores; higher scores reflect better experiences.

    Measured: baseline, immediately after the intervention, 1 month after intervention

  6. Change in gross manual dexterity assessed by the Box and Block Test

    The Box and Block Test assesses gross manual dexterity by counting the number of blocks moved from one compartment to another in one minute. Higher numbers indicate better manual dexterity.

    Measured: baseline, immediately after the intervention, 1 month after intervention

Secondary outcomes (4)
  1. Change in participation in daily activities assessed by the Participation and Environment Measure for Children and Youth (PEM-CY)

    The PEM-CY questionnaire evaluates participation frequency, involvement, and environmental supports and barriers across home, school, and community settings in children and youth. Scores are reported as frequency (number of activities per week), level of involvement (1-5 scale), and percentage of environmental barriers identified. Higher scores in frequency and involvement indicate greater participation, while higher percentages of environmental barriers reflect more challenges. Outcomes will be summarized for each domain (home, school, community) separately.

    Measured: baseline, immediately after the intervention, 1 month after intervention

  2. Change in individual goal achievement assessed by Goal Attainment Scaling (GAS)

    Goal Attainment Scaling (GAS) is a participant-centered outcome measure that evaluates the extent to which individualized rehabilitation goals are achieved. Each participant collaborates with the therapist to set specific goals at baseline, which are rated on a 5-point scale ranging from -2 (much less than expected outcome) to +2 (much more than expected outcome), with 0 representing the expected level of achievement. Higher total GAS scores reflect greater goal attainment and better functional improvement.

    Measured: baseline, immediately after the intervention

  3. Change in occupational performance and satisfaction assessed by the Canadian Occupational Performance Measure (COPM)

    The COPM measures self-perceived performance and satisfaction in daily activities identified as important by the participant or caregiver. Participants rate their performance and satisfaction on a 10-point scale (1-10), with higher scores indicating better performance and greater satisfaction. The primary outcomes are changes in COPM performance and satisfaction scores between baseline and post-intervention assessments.

    Measured: baseline, immediately after the intervention, 1 month after intervention

  4. Change in user satisfaction evaluated with a 5-point Likert-scale questionnaire

    User satisfaction with the intervention will be assessed using a structured questionnaire based on a 5-point Likert scale, ranging from 1 (very dissatisfied) to 5 (very satisfied). The total score will be calculated as the mean of individual item responses. Higher scores indicate greater satisfaction with the rehabilitation protocol and the HOME Kit system. The questionnaire includes items related to usability, comfort, perceived usefulness, and motivation.

    Measured: immediately after the intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jul 2025
  2. Study start1 Mar 2026 (estimated)
  3. Primary completion1 Sep 2026 (estimated)
  4. Study completion1 Apr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
24 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07091461
Sponsor's protocol ID
HOMIMTES-CHilD
Acronym
HOMIMTES-CHilD
Status last verified
Feb 2026
First submitted
7 Jul 2025
Last updated
5 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing HOME Kit Tablet-based Telerehabilitation and Conventional Home Physiotherapy in people with Cerebral Palsy Infantile, run by University of Castilla-La Mancha.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 5 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Rocío Palomo-Carrión, PT PhD (34926051821, Rocio.Palomo@uclm.es), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in postural control assessed by stabilometric platform (time frame: baseline, immediately after the intervention, 1 month after intervention). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Feb 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in